AbCellera Biologics (NASDAQ:ABCL) used its full-year 2025 business update call to emphasize that it has completed its ...
It is an honor and a privilege to lead such a talented and committed team as Arvinas enters a period where we anticipate ...
Exclusive: Harvard geneticist George Church knew more about Jeffrey Epstein's activities than he has previously said, before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results